WebDisclosure WebDisclosure
Basculer en Français
9472 Companies
185369 Keywords
117719 Articles
99261 Press releases
Headlines Articles Press releases Koop Insurance Remove
  1. Home
  2. Companies
  3. Koop Insurance
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/09/2024 at 14:00, 1 year 10 months ago

    Insurtech Koop Insurance Launches Pioneering ERM Automation for Technology Risks

    Koop Technologies, a Jersey City, NJ-based insurtech company, has launched an Enterprise Risk Management (ERM) Automation tool designed specifically for technology companies. This innovative tool aims to enhance security, streamline compliance processes, and reduce insurance costs for technology businesses. Through features such as contractual requirements management, risk events reporting, and smart coverages, the ERM Automation tool offers a comprehensive solution for managing technology-related risks. The tool's introduction reflects Koop's dedication to addressing the evolving needs of technology companies and making ERM more accessible to small-to-mid-sized enterprises.
    Koop Technologies ERM Automation Technology Companies Insurance Costs Compliance Processes
    Logo of Koop Insurance
Accesswire
  • Published on 12/05/2025 at 02:35, 4 hours 6 minutes ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 4 hours 11 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 5 hours 41 minutes ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 7 hours 36 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 7 hours 41 minutes ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 03:30, 3 hours 11 minutes ago

    CGTN: What makes cooperation between China and France a two-way success

  • Published on 12/04/2025 at 23:50, 6 hours 50 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes

  • Published on 12/04/2025 at 20:25, 10 hours 16 minutes ago

    Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

  • Published on 12/04/2025 at 20:15, 10 hours 26 minutes ago

    Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

  • Published on 12/04/2025 at 19:10, 11 hours 31 minutes ago

    SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

View all EQS
Les Echos
  • Published on 12/04/2025 at 18:14, 12 hours 27 minutes ago

    Résiliation d'une convention conclue entre actionnaires

  • Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

  • Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025

  • Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions

  • Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy